HI-Bio is a California-based clinical-stage biotechnology company that develops novel therapies for the treatment of immune-mediated diseases.
Business Model:
Revenue: $1M
Employees: 11-50
Address: -
City: San Francisco
State: CA
Zip: 94016
Country: US
HI-Bio is a California-based clinical-stage biotechnology company that develops novel therapies for the treatment of immune-mediated diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2022 | Equity | $120M |
Jeito Capital ARCH Venture Partners Monograph Capital |
11/2022 | Series A | $0 |
ARCH Venture Partners Jeito Capital Monograph Capital MorphoSys ARCH Venture Partners Jeito Capital Monograph Capital MorphoSys |
11/2022 | Series A | 3 | $120M |
ARCH Venture Partners Jeito Capital Monograph Capital ARCH Venture Partners Jeito Capital Monograph Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|